Cargando…

Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design

The assumptions and models for solubility modelling or prediction in systems using non-polar solvents, or water and complex triterpene and other active pharmaceutical ingredients as solutes aren't well studied. Furthermore, the assumptions concerning heat capacity effects (negligibility, experi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moodley, Kuveneshan, Rarey, Jürgen, Ramjugernath, Deresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032238/
https://www.ncbi.nlm.nih.gov/pubmed/32104400
http://dx.doi.org/10.1016/j.ajps.2017.12.004
_version_ 1783499534449508352
author Moodley, Kuveneshan
Rarey, Jürgen
Ramjugernath, Deresh
author_facet Moodley, Kuveneshan
Rarey, Jürgen
Ramjugernath, Deresh
author_sort Moodley, Kuveneshan
collection PubMed
description The assumptions and models for solubility modelling or prediction in systems using non-polar solvents, or water and complex triterpene and other active pharmaceutical ingredients as solutes aren't well studied. Furthermore, the assumptions concerning heat capacity effects (negligibility, experimental values or approximations) are explored, using non-polar solvents (benzene), or water as reference solvents, for systems with solute melting points in the range of 306–528 K and molecular weights in the range of 90–442 g/mol. New empirical estimation methods for the [Formula: see text] of APIs are presented which correlate the solute molecular masses and van der Waals surface areas with [Formula: see text]. Separate empirical parameters were required for oxygenated and non-oxygenated solutes. Subsequently, the predictive capabilities of the various approaches to solubility modelling for complex pharmaceuticals, for which data is limited, are analysed. The solute selection is based on a principal component analysis, considering molecular weights, fusion temperatures, and solubilities in a non-polar solvent, alcohol, and water, where data was available. New NRTL-SAC parameters were determined for selected steroids, by regression. The original UNIFAC, modified UNIFAC (Dortmund), COSMO-RS (OL), and COSMO-SAC activity coefficient predictions are then conducted, based on the availability of group constants and sigma profiles. These are undertaken to assess the predictive capabilities of these models when each assumption concerning heat capacity is employed. The predictive qualities of the models are assessed, based on the mean square deviation and provide guidelines for model selection, and assumptions concerning phase equilibrium, when designing solid–liquid separators for the pharmaceutical industry on process simulation software. The most suitable assumption regarding [Formula: see text] was found to be system specific, with modified UNIFAC (Dortmund) performing well in benzene as a solvent system, while original UNIFAC performs better in aqueous systems. Original UNIFAC outperforms other predictive models tested in the triterpene/steroidal systems, with no significant influence from the assumptions regarding [Formula: see text].
format Online
Article
Text
id pubmed-7032238
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Shenyang Pharmaceutical University
record_format MEDLINE/PubMed
spelling pubmed-70322382020-02-26 Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design Moodley, Kuveneshan Rarey, Jürgen Ramjugernath, Deresh Asian J Pharm Sci Original Research Article The assumptions and models for solubility modelling or prediction in systems using non-polar solvents, or water and complex triterpene and other active pharmaceutical ingredients as solutes aren't well studied. Furthermore, the assumptions concerning heat capacity effects (negligibility, experimental values or approximations) are explored, using non-polar solvents (benzene), or water as reference solvents, for systems with solute melting points in the range of 306–528 K and molecular weights in the range of 90–442 g/mol. New empirical estimation methods for the [Formula: see text] of APIs are presented which correlate the solute molecular masses and van der Waals surface areas with [Formula: see text]. Separate empirical parameters were required for oxygenated and non-oxygenated solutes. Subsequently, the predictive capabilities of the various approaches to solubility modelling for complex pharmaceuticals, for which data is limited, are analysed. The solute selection is based on a principal component analysis, considering molecular weights, fusion temperatures, and solubilities in a non-polar solvent, alcohol, and water, where data was available. New NRTL-SAC parameters were determined for selected steroids, by regression. The original UNIFAC, modified UNIFAC (Dortmund), COSMO-RS (OL), and COSMO-SAC activity coefficient predictions are then conducted, based on the availability of group constants and sigma profiles. These are undertaken to assess the predictive capabilities of these models when each assumption concerning heat capacity is employed. The predictive qualities of the models are assessed, based on the mean square deviation and provide guidelines for model selection, and assumptions concerning phase equilibrium, when designing solid–liquid separators for the pharmaceutical industry on process simulation software. The most suitable assumption regarding [Formula: see text] was found to be system specific, with modified UNIFAC (Dortmund) performing well in benzene as a solvent system, while original UNIFAC performs better in aqueous systems. Original UNIFAC outperforms other predictive models tested in the triterpene/steroidal systems, with no significant influence from the assumptions regarding [Formula: see text]. Shenyang Pharmaceutical University 2018-05 2017-12-08 /pmc/articles/PMC7032238/ /pubmed/32104400 http://dx.doi.org/10.1016/j.ajps.2017.12.004 Text en © 2018 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research Article
Moodley, Kuveneshan
Rarey, Jürgen
Ramjugernath, Deresh
Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design
title Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design
title_full Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design
title_fullStr Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design
title_full_unstemmed Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design
title_short Model evaluation for the prediction of solubility of active pharmaceutical ingredients (APIs) to guide solid–liquid separator design
title_sort model evaluation for the prediction of solubility of active pharmaceutical ingredients (apis) to guide solid–liquid separator design
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032238/
https://www.ncbi.nlm.nih.gov/pubmed/32104400
http://dx.doi.org/10.1016/j.ajps.2017.12.004
work_keys_str_mv AT moodleykuveneshan modelevaluationforthepredictionofsolubilityofactivepharmaceuticalingredientsapistoguidesolidliquidseparatordesign
AT rareyjurgen modelevaluationforthepredictionofsolubilityofactivepharmaceuticalingredientsapistoguidesolidliquidseparatordesign
AT ramjugernathderesh modelevaluationforthepredictionofsolubilityofactivepharmaceuticalingredientsapistoguidesolidliquidseparatordesign